Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 6 (NDUFA5P6) is a human pseudogene, meaning it is a DNA sequence resembling a gene but is non-functional and does not produce a functional protein product[1][3][5]. Pseudogenes such as NDUFA5P6 often result from gene duplication or retrotransposition and can be remnants of once-functional genes. There is currently no evidence to suggest that NDUFA5P6 acts as a receptor, enzyme, transporter, or is implicated as a therapeutic target in any diseases. No drugs, disease associations, biological functions, or biomarker roles are attributed to this pseudogene. Therefore, references to NDUFA5P6 as a target molecule or receptor are likely incorrect and may reflect misidentification or misunderstanding of genomic nomenclature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 6 (NDUFA5P6).